Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

RAMELTEON 8 MG TABLET

RAMELTEON
$0.7165per EA

Strength

8 mg/1

Manufacturer

Aurobindo Pharma Limited

NDC

59651050530

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RAMELTEON

Approval Type

Generic (ANDA)

FDA Application

ANDA215972

On Market Since

7/10/2023

Pharmacological Classes

Melatonin Receptor Agonist
Melatonin Receptor Agonists

Price History

1W

0.0%

1M

-0.1%

3M

-4.4%

6M

-1.5%

1Y

-11.1%

3Y

N/A

5Y

N/A

All

-22.8%

Generic Alternatives

1 alternative • Same active ingredient

RAMELTEON 8 MG TABLET
Generic
59651050501•Aurobindo Pharma Limited
$0.7165

Related Drugs

Same classification

RAMELTEON 8 MG TABLET
Generic
00591219101•Actavis Pharma, Inc.
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
00591219130•Actavis Pharma, Inc.
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
00832125011•Upsher-Smith Laboratories LLC
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
00832125030•Upsher-Smith Laboratories LLC
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
00904749406•Major Pharmaceuticals
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
42571037501•Micro Labs Limited
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
42571037530•Micro Labs Limited
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
43598074101•Dr. Reddy's Laboratories Inc.
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
43598074130•Dr. Reddy's Laboratories Inc.
$0.7165
per EA
RAMELTEON 8 MG TABLET
Generic
50268070815•AvPAK
$0.7165
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy